Business
Vape ban isn’t working, says waste firm boss
Ben KingBusiness reporter
BiffaThe ban on disposable vapes is failing to stop millions being thrown away incorrectly, and the devices are still causing chaos for the waste industry, a boss at a leading firm has said.
“We’re seeing more vapes in our system, causing more problems, more fires than ever before,” said Roger Wright, the strategy and packaging manager at Biffa.
Vape firms have launched cheap reusable devices, so instead of refilling and recycling them, people were binning them and buying more, he said.
A spokesperson for the vape industry said the June ban had been a success, and any rise in devices being thrown away was likely due to black market trade.
In April and May, the last two months before the ban, Biffa’s recycling facilities in Suffolk, Teesside and London saw around 200,000 vapes on average incorrectly mixed in with general recycling.
For the three months since the ban in June, the average figure has been 3% higher.
Biffa handles almost a fifth of the UK’s waste, and Mr Wright reckons the rest of the industry will be seeing a similar picture, suggesting around a million vapes a month going into general recycling.
This may partly be because large stocks of disposables were sold off cheap before the ban came into force.
But the vape industry’s response to the ban has also contributed, says Mr Wright.
Big vape firms launched a range of reusable models that are very similar to the most popular disposable vapes and sold at similar prices.
By adding a replaceable nicotine pod and a USB recharging port, they can be sold as reusable, but Mr Wright suspects many are still being thrown away.
“We still see a lot of these reusables in the bins, because people have used them as a disposable item,” he says.
The ban has also led to a big increase in the number of different kinds of vapes on the market, as firms launched dozens of new products to try to get round the ban.
“The innovation’s gone crazy to try and get around the ban. Ironically it makes our job of recycling them – if we collect them – much harder,” said Mr Wright.
But Marcus Saxton, chairman of the Independent British Vape Trade Association, argued that the ban has been a success.
“We can see through the data consumers are refilling and recharging devices,” he said.
“So actually, if Biffa’s findings are true, this is about disposable products washing through the system, either through illegal traders or through the illegal black market.”
BiffaVapes contain lithium batteries, which can catch fire when crushed. This often happens in bin lorries or recycling centres – one of the reasons they were banned in June.
They are called “bombs in bins” because of the fires they cause. Vapes should be returned to stores or recycling centres for specialist handling, not added to general recycling or general waste.
In June alone, Biffa had to deal with 60 fires caused by vapes and other small electrical items. Once the fire has occurred, it’s hard to pinpoint the exact cause.
Biffa said dealing with this problem costs the UK waste industry a billion pounds a year.
The ban on disposable vapes was partly designed to curb the many millions of devices that were incorrectly thrown away.
Vapes mixed in with general waste, which is often ultimately incinerated, cause less serious problems than those in general recycling.
Mr Wright said collecting vapes and electrical devices directly from people’s homes alongside general waste and recycling would be part of the solution.
“I think that would massively improve the collection rates,” he said. “You’re more likely to put it out on the kerbside than you are to bother to go down to your corner shop and give it back.” Some councils already do this.
A government spokesperson said: “Single-use vapes get kids hooked on nicotine and blight our high streets – it’s why we’ve taken tough action and banned them.”
It said it has made in compulsory for retailers to provide recycling bins, and its circular economy strategy due later this year aims to increase the reuse and recycling of electrical equipment.
A shopper carries Nike bags in San Francisco, California, US, on Wednesday, Dec. 17, 2025.
David Paul Morris | Bloomberg | Getty Images
Nike on Thursday posted quarterly earnings and revenue that topped Wall Street’s estimates, as strength in North America helped to offset a plunge in China sales.
The company’s stock slid more than 6% in extended trading Thursday, as investors digested the weakness in China and the sustained hit Nike is taking from higher tariffs.
Here’s what Nike reported for its second fiscal quarter of 2026, according to consensus estimates from LSEG:
- Earnings per share: 53 cents vs. 38 cents expected
- Revenue: $12.43 billion vs. $12.22 billion expected
The athletic apparel retailer said sales in North America rose 9% to $5.63 billion. But revenue in its Greater China market dropped 17% to $1.42 billion.
The sneaker company is just over a year into CEO Elliott Hill’s turnaround strategy, focusing on regaining its growth and market share, clearing out old inventory and investing in wholesale relationships.
“Fiscal year ’26 continues to be a year of taking action to rightsize our classics business, return Nike digital to a premium experience, diversify our product portfolio, deepen our consumer connection, strengthen our partner relationships and realign our teams and leadership,” Hill said on a call with analysts. “And I say we’re in the middle inning of our comeback.”
“We’re nowhere near our potential,” he added.
Hill said Nike’s improvements in its China market are “not happening at the level or the pace we need to drive wider change,” though he said the country remains one of the company’s most powerful long-term opportunities.
Nike expects fiscal third quarter revenues to fall by a low single digit percentage, with modest growth in North America. It also anticipates gross margins will drop 1.75 to 2.25 percentage points – including a 3.15 percentage point hit from tariffs.
The company said wholesale revenues climbed 8% to $7.5 billion during the quarter. But direct sales — which were a focus for Nike in the years before Hill took over and moved away from the strategy — fell 8% to $4.6 billion.
Nike has also been feeling the impact of tariff increases. It said Thursday that its gross margin decreased by 3 percentage points and inventories dropped 3% primarily due to higher tariffs.
The sneaker company has been reporting weakness in its Converse brand, too. In its first fiscal quarter, Nike said Converse sales dropped 27% – on Thursday, it reported a 30% drop in revenues for the sneaker brand.
Despite the weakness in some parts of Nike’s business, the company highlighted some areas of strength and new initiatives ahead. CFO Matt Friend said on the call that Nike.com posted its best Black Friday ever this year, partially driven by its Air Jordan “Black Cat” launch.
Nike also plans to launch a new footwear platform in January called Nike Mind, which aims to help athletes prepare for performance and competition, Hill said on the call.
Nike has been making larger internal changes under Hill.
Earlier this month, Nike underwent leadership changes to “remove layers,” according to Hill. Under its “Win Now” strategy, the company announced that Chief Commercial Officer Craig Williams would leave the sneaker giant.
Hill called the shakeup a move “about growth and offense.”
“Collectively, these changes amount to us eliminating layers and better positioning Nike to continue to have an impact the way only Nike can,” Hill said in a statement at the time.
Nike shares have dropped more than 13% this year as of Thursday’s close.
U.S. President Donald Trump sits in the Oval Office to sign executive orders, at the White House in Washington, D.C., U.S., Dec. 18, 2025.
Evelyn Hockstein | Reuters
President Donald Trump signed an executive order Thursday directing federal agencies to reclassify marijuana, loosening long-standing restrictions on the drug and marking the most consequential shift in U.S. cannabis policy in more than half a century.
The order, once finalized by the Drug Enforcement Administration, moves cannabis out of Schedule I classification — the most restrictive category under the Controlled Substances Act, alongside heroin and LSD — to a Schedule III classification, which encompasses substances with accepted medical use and a lower potential for abuse, such as ketamine and Tylenol with codeine.
“This action has been requested by American patients suffering from extreme pain, incurable diseases, aggressive cancers, seizure disorders, neurological problems and more, including numerous veterans with service-related injuries, and older Americans who live with chronic medical problems that severely degrade their quality of life,” Trump said from the Oval Office on Thursday.
Also on Thursday, the Centers for Medicare and Medicaid Services, led by Dr. Mehmet Oz, is expected to launch a pilot program in April enabling certain Medicare-covered seniors to receive free, doctor-recommended CBD products, which must comply with all local and state laws on quality and safety, according to senior White House officials. The products must also come from a legally compliant source and undergo third-party testing for CBD levels and contaminants.
Shares of cannabis conglomerates were down following the announcement, likely from worries of new compeititon from international companies.
Trulieve’s stock finished the day down about 23%, Green Thumb Industries fell more than 16% and Tilray Brands fell about about 4% as of close on Thursday. The AdvisorShares Pure US Cannabis ETF, which tracks American operators, slid almost 27%.
“Millions of registered patients across the United States, many of them veterans, rely on cannabis for relief from chronic and debilitating symptoms. We commend the administration for taking this historic step. This is only the beginning,” Ben Kovler, founder and CEO of Green Thumb, said in a statement to CNBC.
The reclassification is viewed by many analysts as a financial lifeline for the cannabis industry. The move exempts companies from IRS Code Section 280E, allowing them to deduct standard expenses like rent and payroll for the first time. It also opens the door for banking access and institutional capital previously sidelined by compliance fears.
Many on Wall Street also expect the changes and the Medicare pilot to draw major pharmaceutical players into the sector to chase federally insured revenue.
While CBD has surged in popularity in recent years, with infused consumer goods ranging from seltzers to skin care, the Food and Drug Administration has stopped short of granting the compound its full backing.
Studies have found “inconsistent benefits” for targeted conditions, while FDA-funded research warns that prolonged CBD use can cause liver toxicity and interfere with other lifesaving medications.
Currently, the FDA has only approved one CBD-based drug, Epidiolex, for rare forms of epilepsy.
“I want to emphasize that the order … doesn’t legalize marijuana in any way, shape or form, and in no way sanctions its use as a recreational drug,” Trump said.
Experts and industry insiders told CNBC this week that a reclassification could pave the way for more research into the effects of CBD use.
NEW DELHI: The new nuclear energy bill, which was passed in Rajya Sabha by voice vote after a four-hour discussion while rejecting many amendments moved by opposition to send it to a parliamentary panel for scrutiny, marks a decisive shift in India’s nuclear governance, embedding safety oversight in law across the lifecycle of an atomic plant, unlike the existing framework that relied largely on executive discretion and post-accident accountability.Sustainable Harnessing of Nuclear Energy for Transforming India (SHANTI) Bill will allow private participation in India’s tightly controlled civil nuclear sector as the country seeks to meet its clean energy goals by 2047. As opposition raised safety and liability concerns, officials said it establishes a statutory safety regime that ensures continuous compliance rather than reliance on one-time permissions. It seeks to provide for a “pragmatic civil liability regime for nuclear damage and confer statutory status to Atomic Energy Regulatory Board (AERB)”.Officials said unlike the previous law – in which nuclear safety oversight was shaped largely by broad executive authority and administrative rules – SHANTI fundamentally recasts the framework by shifting to a “statutory, lifecycle-based regulatory regime”. Govt manages radiation risks and radioactive waste, but does not mandate separate safety authorisations or legally bind safety obligations to each phase of a nuclear plant’s life. AERB’s stage-wise consent process for construction, commissioning and operation existed only as an administrative practice. Civil Liability for Nuclear Damage (CLND) Act, 2010 further reinforced a post-accident approach by focusing on compensation and insurance rather than prevention.“These laws (Atomic Energy Act and CLND Act) treated safety primarily as a post-damage responsibility, rather than a proactive governance requirement,” said an official. SHANTI separates “permission to operate” from “permission to operate safely”, requiring both a licence and an independent safety authorisation. Any activity involving radiation exposure risk – including construction, operation, transport, storage, decommissioning, or waste management – will now require explicit safety approval.It also consolidates regulation, enforcement, civil liability and dispute resolution within a single statute, reducing legal complexity and compliance uncertainty. “It grants a clear statutory authority to AERB to inspect facilities, investigate incidents, issue binding directions, and suspend or cancel operations that do not meet safety standards. Regulatory action is no longer dependent on executive discretion. Accident prevention is significantly enhanced by legally recognising serious risk situations as nuclear incidents, even without actual damage,” said the official. Core functions such as fuel enrichment, spent-fuel reprocessing, and heavy water production will remain exclusively under Centre’s control.Anujesh Dwivedi, partner at Deloitte India, said continuing with the existing legal framework would make it difficult for nuclear energy to replace thermal power in the long run. “Over decades, India added only about 8GW of nuclear capacity. Scaling this up to 100GW by 2047- and potentially 300GW or more by 2070 – required major reforms, which these regulations seek to address,” he said.Meanwhile, PM Modi said passing of the bill marks a “transformational moment for our technology landscape”.
Ex-NASCAR star Greg Biffle, family members killed in North Carolina plane crash
Victoria Beckham ‘won’t let family feud ruin Christmas’
Violence erupts in Bangladesh after wounded youth leader dies
-
Business5 days agoHitting The ‘High Notes’ In Ties: Nepal Set To Lift Ban On Indian Bills Above ₹100
-
Politics1 week agoTrump launches gold card programme for expedited visas with a $1m price tag
-
Business1 week agoRivian turns to AI, autonomy to woo investors as EV sales stall
-
Sports1 week agoPolice detain Michigan head football coach Sherrone Moore after firing, salacious details emerge: report
-
Fashion1 week agoTommy Hilfiger appoints Sergio Pérez as global menswear ambassador
-
Business1 week agoCoca-Cola taps COO Henrique Braun to replace James Quincey as CEO in 2026
-
Sports1 week agoU.S. House passes bill to combat stadium drones
-
Tech1 week agoGoogle DeepMind partners with UK government to deliver AI | Computer Weekly